BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 24, 2017
View Archived Issues
Attune reports preclinical data on ATN-249 for treatment of hereditary angioedema
Read More
MATRIX trials reveal postoperative pain reduction with bupivacaine-collagen matrix INL-001
Read More
EMA grants orphan drug designation to avacopan for C3 glomerulopathy
Read More
Churchill Pharmaceuticals submits NDA for Yonsa
Read More
United Neuroscience reports phase I data on UB-311 for Alzheimer's disease
Read More
Dose-dependent effects of intranasal oxytocin evaluated in autism spectrum disorders
Read More
Global BioLife begins research on universal therapeutic drug platform
Read More
DNAnexus partners with AstraZeneca on genomics informatics
Read More
MK-7264 shows significant efficacy in patients with refractory chronic cough
Read More
FDA grants accelerated approval to Keytruda and priority review for further indication
Read More
Imfinzi available in U.S.
Read More
GlaxoSmithKline describes novel CPHPC prodrugs
Read More
Oryx reports data on ParvOryx combination therapy in GBM
Read More
Sutter Health, Dignity Health patent podophyllotoxin and camptothecin derivatives
Read More
Calithera Biosciences presents new arginase inhibitors
Read More
OSE and Selexis sign commercial license agreement
Read More
Northwestern University patents MNK1/2 inhibitors
Read More
Palladio Biosciences acquires rights to lixivaptan
Read More
WHO Situation Report documents rise in Ebola cases/New antibodies described
Read More
Phase III study of Livatag recommended to continue
Read More
Debiopharm acquires ImmunoGen's ADC IMGN-529
Read More
Spring Bank releases initial cohort data from phase IIa study of SB-9200 in HBV
Read More
FDA and EMA accept submissions for UX-003 for mucopolysaccharidosis VII
Read More
Neurocrine reports phase II data on Ingrezza in Tourette's syndrome
Read More
FDA grants breakthrough therapy designation to plazomicin
Read More
Pierre Fabre acquires immuno-oncology assets from Igenica Biotherapeutics
Read More
A new zebrafish model of amyotrophic lateral sclerosis shows relevance of the Nefl protein
Read More